Clinical Study on the Prevention and Treatment of Postoperative Metastasis of Lung Cancer by Fuzheng Quxie Recipe - Trial NCT06381960
Access comprehensive clinical trial information for NCT06381960 through Pure Global AI's free database. This Phase 2 trial is sponsored by Jianhui Tian and is currently Recruiting. The study focuses on Lung Cancer. Target enrollment is 356 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jianhui Tian
Shanghai Municipal Hospital of Traditional Chinese Medicine
Timeline & Enrollment
Phase 2
Mar 01, 2023
Dec 31, 2025
Primary Outcome
Disease-free survival, DFS
Summary
To address the clinical challenge of postoperative metastasis in stage IIA-IIIA non-small
 cell lung cancer with negative driver gene expression, there is a lack of effective
 diagnostic and therapeutic measures. Based on this, investigators propose to carry out a
 clinical study on the prevention and treatment of postoperative metastasis of IIA-IIIA stage
 lung cancer with negative driver gene expression with the formula of supporting the positive
 and dispelling the evil.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06381960
Non-Device Trial